HAMLET BIOPHARMA AB SER. BHAMLET BIOPHARMA AB SER. BHAMLET BIOPHARMA AB SER. B

HAMLET BIOPHARMA AB SER. B

No trades
See on Supercharts

HAMLET.B fundamentals

An in-depth look to HAMLET BIOPHARMA AB SER. B operating, investing, and financing activities

HAMLET.B free cash flow for Q3 25 is -10.39 M SEK. For 2024, HAMLET.B free cash flow was -36.28 M SEK and operating cash flow was -36 M SEK.

Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SEK
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
TTM
Free cash flowYoY growth